Staging of prostate cancer with [18F]PSMA-1007-PET/CT versus Na[18F]F-PET/CT: Diagnostic accuracy, influence on staging and patient management, and evaluation of patient benefit: Results from the PRISMA-PET trial

Bidragets oversatte titel: Stadieinddeling af prostatacancer med [18F]PSMA-1007-PET/CT versus Na[18F]F-PET/CT: Diagnostisk akkuratesse, påvirkning af stadieinddeling og behandling af patienterne samt en evaluering af patienternes gavn af forskellene.: Resultater fra PRISMA-PET forsøget

Karen M Buch-Olsen

Publikation: Afhandling › Ph.d.-afhandling

28 Downloads (Pure)

2 Tidsskriftartikel

2 resultater

Filter

2026
Primary Staging of Intermediate- and High-Risk Prostate Cancer Using [18F]PSMA-1007 PET/CT and [18F]NaF PET/CT: A Head-to-Head Comparison of Diagnostic Accuracy, Staging, and Patient Management
Buch-Olsen, K. M., Vilstrup, M. H., Hansen, S., Poulsen, M. H., Holdgaard, P. C., Zieger, K. E. A., Holm, J., Pedersen, K. T., Hess, S., Eiber, M., Gerke, O. & Hildebrandt, M. G., 1. jan. 2026, I: The Journal of Nuclear Medicine. 67, 1, s. 71-78
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
1 Downloads (Pure)
2023
A randomised trial of [18F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol
Buch‐Olsen, K. M., Poulsen, M. H., Hansen, S., Vilstrup, M. H., Holm, J., Hess, S., Holdgaard, P. C., Zieger, K. E. A., Madsen, S. S., Gerke, O., Pedersen, K. T., Dam, J. H., Langkjær, N., Østergaard, L. D., Asmussen, J. T., Braad, P. E., Nørgaard, B., Eiber, M. & Hildebrandt, M. G., sep. 2023, I: BJUI Compass. 4, 5, s. 513-522
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Åben adgang
Fil
79 Downloads (Pure)

Staging of prostate cancer with [18F]PSMA-1007-PET/CT versus Na[18F]F-PET/CT: Diagnostic accuracy, influence on staging and patient management, and evaluation of patient benefit: Results from the PRISMA-PET trial

Relaterede publikationer

Søgeresultater

2026

Primary Staging of Intermediate- and High-Risk Prostate Cancer Using [18F]PSMA-1007 PET/CT and [18F]NaF PET/CT: A Head-to-Head Comparison of Diagnostic Accuracy, Staging, and Patient Management

2023

A randomised trial of [18F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol